Ranked #1
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis
Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety o... Read more
10 Aug 2023
•
14mins
Ranked #2
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-inv... Read more
12 Jul 2023
•
17mins
Similar Podcasts
American Journal of Gastroenterology Author Podcasts
NEJM Interviews
The Intern At Work: Internal Medicine
The Clinical Problem Solvers
Freakonomics, M.D.
Ranked #3
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis
Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on... Read more
7 Jun 2023
•
12mins
Ranked #4
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs
Adelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of H... Read more
10 May 2023
•
17mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
Johan Burisch on the costs of inflammatory bowel disease in high-income settings
Johan Burisch on the costs of inflammatory bowel disease in high-income settings
Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroe... Read more
12 Apr 2023
•
20mins
Ranked #6
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease
Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concom... Read more
8 Feb 2023
•
21mins
Ranked #7
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer
Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant ther... Read more
23 Jan 2023
•
20mins
Ranked #8
Dan Turner on vedolizumab in children with IBD
Dan Turner on vedolizumab in children with IBD
Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedoli... Read more
6 Jan 2023
•
14mins
Ranked #9
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faeca... Read more
9 Nov 2022
•
15mins
Ranked #10
James Alexander on immune responses to COVID-19 vaccination in patients with IBD
James Alexander on immune responses to COVID-19 vaccination in patients with IBD
James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is invest... Read more
5 Oct 2022
•
13mins
